Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates

Joseph R. Mazzulli, Amanda J. Mishizen, Benoit I. Giasson, David R. Lynch, Steven A. Thomas, Akira Nakashima, Toshiharu Nagatsu, Akira Ota, Harry Ischiropoulos

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Aberrant aggregation of α-synuclein (α-syn) to form fibrils and insoluble aggregates has been implicated in the pathogenic processes of many neurodegenerative diseases. Despite the dramatic effects of dopamine in inhibiting the formation of α-syn fibrils by stabilization of oligomeric intermediates in cell-free systems, no studies have examined the effects of intracellular dopamine on α-syn aggregation. To study this process and its association with neurodegeneration, intracellular catechol levels were increased to various levels by expressing different forms of tyrosine hydroxylase, in cells induced to form α-syn aggregates. The increase in the steady-state dopamine levels inhibited the formation of α-syn aggregates and induced the formation of innocuous oligomeric intermediates. Analysis of transgenic mice expressing the disease-associated A53T mutant α-syn revealed the presence of oligomeric α-syn in nondegenerating dopaminergic neurons that do contain insoluble α-syn. These data indicate that intraneuronal dopamine levels can be a major modulator of α-syn aggregation and inclusion formation, with important implications on the selective degeneration of these neurons in Parkinson's disease.

Original languageEnglish
Pages (from-to)10068-10078
Number of pages11
JournalJournal of Neuroscience
Volume26
Issue number39
DOIs
Publication statusPublished - 27-09-2006

Fingerprint

Synucleins
Catechols
Dopamine
Nerve Degeneration
Cell-Free System
Dopaminergic Neurons
Tyrosine 3-Monooxygenase
Neurodegenerative Diseases
Transgenic Mice
Parkinson Disease

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Mazzulli, Joseph R. ; Mishizen, Amanda J. ; Giasson, Benoit I. ; Lynch, David R. ; Thomas, Steven A. ; Nakashima, Akira ; Nagatsu, Toshiharu ; Ota, Akira ; Ischiropoulos, Harry. / Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. In: Journal of Neuroscience. 2006 ; Vol. 26, No. 39. pp. 10068-10078.
@article{950a430cdef94aa7839474557b68988b,
title = "Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates",
abstract = "Aberrant aggregation of α-synuclein (α-syn) to form fibrils and insoluble aggregates has been implicated in the pathogenic processes of many neurodegenerative diseases. Despite the dramatic effects of dopamine in inhibiting the formation of α-syn fibrils by stabilization of oligomeric intermediates in cell-free systems, no studies have examined the effects of intracellular dopamine on α-syn aggregation. To study this process and its association with neurodegeneration, intracellular catechol levels were increased to various levels by expressing different forms of tyrosine hydroxylase, in cells induced to form α-syn aggregates. The increase in the steady-state dopamine levels inhibited the formation of α-syn aggregates and induced the formation of innocuous oligomeric intermediates. Analysis of transgenic mice expressing the disease-associated A53T mutant α-syn revealed the presence of oligomeric α-syn in nondegenerating dopaminergic neurons that do contain insoluble α-syn. These data indicate that intraneuronal dopamine levels can be a major modulator of α-syn aggregation and inclusion formation, with important implications on the selective degeneration of these neurons in Parkinson's disease.",
author = "Mazzulli, {Joseph R.} and Mishizen, {Amanda J.} and Giasson, {Benoit I.} and Lynch, {David R.} and Thomas, {Steven A.} and Akira Nakashima and Toshiharu Nagatsu and Akira Ota and Harry Ischiropoulos",
year = "2006",
month = "9",
day = "27",
doi = "10.1523/JNEUROSCI.0896-06.2006",
language = "English",
volume = "26",
pages = "10068--10078",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "39",

}

Mazzulli, JR, Mishizen, AJ, Giasson, BI, Lynch, DR, Thomas, SA, Nakashima, A, Nagatsu, T, Ota, A & Ischiropoulos, H 2006, 'Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates', Journal of Neuroscience, vol. 26, no. 39, pp. 10068-10078. https://doi.org/10.1523/JNEUROSCI.0896-06.2006

Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. / Mazzulli, Joseph R.; Mishizen, Amanda J.; Giasson, Benoit I.; Lynch, David R.; Thomas, Steven A.; Nakashima, Akira; Nagatsu, Toshiharu; Ota, Akira; Ischiropoulos, Harry.

In: Journal of Neuroscience, Vol. 26, No. 39, 27.09.2006, p. 10068-10078.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates

AU - Mazzulli, Joseph R.

AU - Mishizen, Amanda J.

AU - Giasson, Benoit I.

AU - Lynch, David R.

AU - Thomas, Steven A.

AU - Nakashima, Akira

AU - Nagatsu, Toshiharu

AU - Ota, Akira

AU - Ischiropoulos, Harry

PY - 2006/9/27

Y1 - 2006/9/27

N2 - Aberrant aggregation of α-synuclein (α-syn) to form fibrils and insoluble aggregates has been implicated in the pathogenic processes of many neurodegenerative diseases. Despite the dramatic effects of dopamine in inhibiting the formation of α-syn fibrils by stabilization of oligomeric intermediates in cell-free systems, no studies have examined the effects of intracellular dopamine on α-syn aggregation. To study this process and its association with neurodegeneration, intracellular catechol levels were increased to various levels by expressing different forms of tyrosine hydroxylase, in cells induced to form α-syn aggregates. The increase in the steady-state dopamine levels inhibited the formation of α-syn aggregates and induced the formation of innocuous oligomeric intermediates. Analysis of transgenic mice expressing the disease-associated A53T mutant α-syn revealed the presence of oligomeric α-syn in nondegenerating dopaminergic neurons that do contain insoluble α-syn. These data indicate that intraneuronal dopamine levels can be a major modulator of α-syn aggregation and inclusion formation, with important implications on the selective degeneration of these neurons in Parkinson's disease.

AB - Aberrant aggregation of α-synuclein (α-syn) to form fibrils and insoluble aggregates has been implicated in the pathogenic processes of many neurodegenerative diseases. Despite the dramatic effects of dopamine in inhibiting the formation of α-syn fibrils by stabilization of oligomeric intermediates in cell-free systems, no studies have examined the effects of intracellular dopamine on α-syn aggregation. To study this process and its association with neurodegeneration, intracellular catechol levels were increased to various levels by expressing different forms of tyrosine hydroxylase, in cells induced to form α-syn aggregates. The increase in the steady-state dopamine levels inhibited the formation of α-syn aggregates and induced the formation of innocuous oligomeric intermediates. Analysis of transgenic mice expressing the disease-associated A53T mutant α-syn revealed the presence of oligomeric α-syn in nondegenerating dopaminergic neurons that do contain insoluble α-syn. These data indicate that intraneuronal dopamine levels can be a major modulator of α-syn aggregation and inclusion formation, with important implications on the selective degeneration of these neurons in Parkinson's disease.

UR - http://www.scopus.com/inward/record.url?scp=33749170166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749170166&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.0896-06.2006

DO - 10.1523/JNEUROSCI.0896-06.2006

M3 - Article

C2 - 17005870

AN - SCOPUS:33749170166

VL - 26

SP - 10068

EP - 10078

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 39

ER -